Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines
Open Access
- 20 May 2023
- journal article
- review article
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 12,p. 4-68
Abstract
Summary Post- COVID syndrome refers to the long-term consequences of a new coronavirus infection COVID-19, which includes a set of symptoms that develop or persist after COVID-19. Symptoms of gastrointestinal disorders in post- COVID syndrome, due to chronic infl ammation, the consequences of organ damage, prolonged hospitalization, social isolation, and other causes, can be persistent and require a multidisciplinary approach. The presented clinical practice guidelines consider the main preventive and therapeutic and diagnostic approaches to the management of patients with gastroenterological manifestations of postCOVID syndrome. The Guidelines were approved by the 17th National Congress of Internal Medicine and the 25th Congress of Gastroenterological Scientifi c Society of Russia.Keywords
This publication has 395 references indexed in Scilit:
- Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and ChinaClinical Drug Investigation, 2014
- IAP/APA evidence-based guidelines for the management of acute pancreatitisPancreatology, 2013
- Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromeCochrane Database of Systematic Reviews, 2011
- A review of laxative therapies for treatment of chronic constipation in older adultsThe American Journal of Geriatric Pharmacotherapy, 2010
- Lactulose versus Polyethylene Glycol for Chronic ConstipationCochrane Database of Systematic Reviews, 2010
- Management of Recurrence of Symptoms of Gastroesophageal Reflux Disease: Synergistic Effect of Rebamipide with 15 mg LansoprazoleDigestive Diseases and Sciences, 2010
- Treatment of Chronic Constipation: Current Pharmacologic Approaches and Future DirectionsClinical Gastroenterology and Hepatology, 2009
- Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 DiabetesJAMA, 2006
- S-Adenosylmethionine in the treatment of intrahepatic cholestasis of chronic liver disease: A field trialCurrent Therapeutic Research, 1999
- Differential Expression Pattern Of S –Adenosylmethionine Synthetase Isoenzymes During Rat Liver DevelopmentHepatology, 1996